Skip to main content
European Commission logo print header

DEVELOPMENT OF ANTIMICROBIAL, ANTIVIRAL, AND ANTIFUNGAL NANOCOATINGS FOR EVERYDAY SURFACES

Project description

Antimicrobial nanocoatings

The risk of contracting viral and bacterial infections in certain environments such as hospitals is significant and necessitates specific and urgent measures. The EU-funded MIRIA project aims to address this challenge by developing antimicrobial nanotechnology-based coatings that can cover various surfaces, including medical equipment, in settings with high contagion risk. The generated nanocoatings will be tested for efficacy against a wide range of microorganisms, including bacteria, fungi and viruses. The most efficient candidates will be brought to the market to improve EU health. Project deliverables are of particular relevance to SARS-CoV-2 spread.

Objective

Since the end of 2019, the spread of COVID has deeply changed our lifestyle, resulting in historical events and decisions, such as the EU block of non-essential travel among countries (COMM (2020) 499), affecting the whole EU society economically and psychologically. However, as reported in the HERA target priorities, the persistence of the emergency status requires daily actions that tackle the spread of COVID.
In this economical, societal and clinical context, the project MIRIA aims to develop wide-range-antimicrobial nanocoatings to be used in hospitals and other environments where cross-contamination and contagion risk are significant issues.
In the wake of the covid outbreak, there has been large concern about infection spread of pathogens (i.e. bacteria, fungi, virus, and specifically SARS-CoV-2) via high traffic surfaces (i.e. medical equipment). State of the art and commercial products coating solutions that both target a range of mixed pathogens and different surfaces (e.g. glass, metal, textile) are unfortunately scant. MIRIA solutions aim to fill this void, impacting on EU health, both directly (by creating public safe environments) and indirectly (by reducing COVID spreading and decreasing ill-related work absences and psychological pathologies). A reduction of the work absence of at least 5% with respect to the 2020 value (15M in EU) is expected.
MIRIA main challenging ambition is to develop nanocoatings with a 99.99% effectiveness against a wide range of pathogens, especially SARS-CoV-2. This will be based on a four pieces puzzle: the knowledge in anti-microbial materials, nanopowders, nanocoating and pilot plant conduction. These nanocoatings will be brought to pilot scale (TRL6) and, within 3 years after the end of the project, they are foreseen to enter the market (TRL9). The exploitation of MIRIA outputs deeply involves SMEs and the dissemination plan will follow a spill-over strategy in order to involve public and private stakeholders.

Keywords

æ

Coordinator

RINA CONSULTING - CENTRO SVILUPPO MATERIALI SPA
Net EU contribution
€ 1 175 000,00
Address
Via di castel romano 100
00128 Roma
Italy

See on map

Region
Centro (IT) Lazio Roma
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Other funding
€ 0,00

Participants (14)